BIODIVERSITY AMENDEMENT BILL, 2021

Related Articles

SOUTH CHINA SEA

September 30, 2023

Forced labour and modern-day slavery

September 28, 2023

India and Ukraine

September 27, 2023

• Recently, a Joint Parliamentary Committee (JPC) that examined the Biological Diversity (Amendment) Bill 2021, has submitted its suggestions on the Bill.
• The JPC has accepted several amendments made by the Ministry of Environment & Climate Change (MoEFCC).
• The Biological Diversity Act, 2002 (BDA) was enacted to provide for the conservation of biological diversity, sustainable use of its components, and fair and equitable sharing of the benefits arising out of the use of biological resources and traditional knowledge.

Features:

The Act prohibits any person or organisation from obtaining any biological resource, occurring in India for its research or commercial utilisation, without prior approval from the National Biodiversity Authority.

The act envisaged a three-tier structure to regulate the access to biological resources:

1. The National Biodiversity Authority (NBA)
2. The State Biodiversity Boards (SBBs)
3. The Biodiversity Management Committees (BMCs) (at local level)
4. The act stipulates all offences under it as cognizable and non-bailable.

Amendments Made in Biodiversity Bill 2021

• Boosting Indian Medicine System: It seeks to give a fillip to “Indian system of medicine”, and facilitate fast-tracking of research, patent application process, transfer of research results while utilising the biological resources available in India.
• It seeks to empower local communities to be able to utilise resources, particularly of medicinal value, such as seeds.
• The Bill looks to encourage farmers to increase cultivation of medicinal plants.
• These objectives to be achieved without compromising the objectives of the United Nation Convention on Biological Diversity.
• Decriminalising Certain Provisions: It seeks to decriminalise certain provisions in the chain of biological resources.
• These changes were brought in consonance with India’s ratification of Nagoya Protocol(Access to generic resources and the fair and equitable sharing of benefits arising from their utilisation) in 2012.
• Allowing Foreign Investments: It also allows for foreign investment in research into biodiversity. However, this investment will necessarily have to be made through Indian companies involved in biodiversity research.
• For foreign entities approval from the National Biodiversity Authority is necessary.
• Exempting AYUSH Practitioners: The Bill seeks to exempt registered AYUSH medical practitioners and people accessing codified traditional knowledge, among others, from giving prior intimation to State biodiversity boards for accessing biological resources for certain purposes.

Concerns Against The Proposed Amendments

• Concerns were raised that the bill prioritised intellectual property and commercial trade at the expense of the act’s key aim of conserving biological resources.
• The exemptions to AYUSH Practitioners from giving prior intimation to State biodiversity boards would pave the way for “bio piracy”.
• Biopiracy is the practice of exploiting naturally occurring genetic or biochemical material in commerce.
• The proposed amendments allow for state biodiversity boards to represent BMCs to determine terms of benefit sharing.
• Under the BDA 2002, national and state biodiversity boards are required to consult the BMCs (constituted by every local body) while taking any decision relating to the use of biological resources.
• The bill also exempts cultivated medicinal plants from the purview of the Act. However, it is practically impossible to detect which plants are cultivated and which are from the wild.
• This provision could allow large companies to evade the requirement for prior approval or share the benefit with local communities under the access and benefit-sharing provisions of the Act. 

Recommendations

• The JPC recommended that biodiversity management committees under the proposed law and indigenous communities should be empowered by clearly defining benefit claimers to be conservers of biological resources.
• Reduce the pressure on wild medicinal plants by encouraging cultivation of medicinal plants.
• Indian system of medicine should be encouraged by clearly defining codified traditional knowledge.
• Promoting indigenous research and Indian companies through facilitating fast-tracking of research, patent application process, transfer of research results while utilising the biological resources available in India without compromising the objectives of Internation biodiversity convention.

SOURCE: THE HINDU,THE ECONOMIC TIMES,MINT